Status: current, Primitive. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3510171011 | Tumor necrosis factor alpha inhibitor (disposition) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3510172016 | Tumor necrosis factor alpha inhibitor | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3510173014 | Tumour necrosis factor alpha inhibitor | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tumour necrosis factor alpha inhibitor | Is a | Immunomodulator | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Certolizumab pegol | Has disposition | True | Tumour necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Golimumab | Has disposition | True | Tumour necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Infliximab | Has disposition | True | Tumour necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Etanercept | Has disposition | True | Tumour necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Adalimumab | Has disposition | True | Tumour necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Tumour necrosis factor alpha inhibitor | Has disposition | True | Tumour necrosis factor alpha inhibitor | Inferred relationship | Some |
Reference Sets
Qualifier value foundation reference set
FHIR